Innovative Measures of Oral Medication Adherence for HIV Treatment and Prevention (R01)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to solicit innovative research applications that seek to advance the development of bioanalytical assays, pill ingestion sensors, drug metabolite and taggant detection systems, or wireless technologic approaches for monitoring and improving adherence to oral antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP).

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedDec 1, 2014
  • ClosesMar 25, 2015
  • Program funding$7,000,000
  • CFDA93.242, 93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro